Indian DNA Vaccine market is anticipated to grow at a CAGR 44.3% during the forecast period. The factors that are driving the market include increasing chronic disease and the awareness towards the DNA vaccine adoption. India is one of the fastest growing economies across the globe and thus is a considerable market for the DNA vaccine. Several biopharmaceuticals, especially DNA based vaccines having therapeutic potential to substitute available vaccines, are under developmental phase. However, these require scientific and regulatory validation with development of suitable guidelines on assessing their safety.
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/indian-dna-vaccines-market
The vaccines that were developed in recent years have become economically viable and have the potential for specified activity of improving the resistance titers against disease. Among the various vaccines required in India for various diseases, the fatal rabies is the most important. According to the Indian Journal for Medical Science the anti-rabies vaccines that were conventionally produced from neural tissues were implicated to be the cause for mortality of more than 40,000 animals per year.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/indian-dna-vaccines-market
The market is segmented on the basis of type, application and technology. Based on type, the market is segmented into animal DNA vaccine and human DNA vaccine. Based on technology, the market is segmented into plasmid DNA vaccine and plasmid DNA delivery. Based on application, the market is segmented into oncology, infectious disease and others.
The key market players that are active in the market includes Asteel Pharma Inc., Bharat Biotech Ltd., Eli Lilly and Co., GE Healthcare, Glaxosmithkline PLC., Indian Immunologicals Ltd., Merck & Co., Pfizer Inc., Roche Diagnostics GMBH and Serum Institute of India Pvt. Ltd. Bharat Biotech Ltd contributing in the DNA vaccine market in India. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market. For instance, in March 2019, Novavax Inc and Bharat Biotech Ltd had announced a strategic alliance to pursue the rapid development of pandemic influenza vaccine for India and certain other south Asian markets.
Market Segmentation
• Indian DNA Vaccine Market by Type
• Animal DNA Vaccine
• Human DNA Vaccine
• Indian DNA Vaccine Market by Technology
• Plasmid DNA Vaccine
• Plasmid DNA Delivery
• Indian DNA Vaccine Market by Application
• Oncology
• Infectious Disease
• Others
Company Profiles
• Asteel Pharma Inc.
• Bharat Biotech Ltd.
• Eli Lilly and Co.
• GE Healthcare
• Glaxosmithkline PLC.
• Indian Immunologicals Ltd.
• Merck & Co.
• Pfizer Inc.
• Roche Diagnostics GMBH
• Serum Institute of India Pvt. Ltd

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/indian-dna-vaccines-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404